Passing on PCOS: new insights into its epigenetic transmission
These findings suggest that gastrointestinal distension serves as a physiological stimulus for GLP-1 secretion and that this mechanism may be effective in preventing and ameliorating hyperphagic obesity
Alice May | 26/02/2026 Finally a product that works for drooping eyelids
Specifically, Skovronsky noted a goal to deliver efficacy similar to injectable GLP-1 monotherapy in an easy-to-use daily pill. Skovronsky added that we expect results from up to six phase III studies by the end of 2026, and expect retatrutide can deliver deeper and more rapid weight-loss than existing obesity medicines, even more than tirzepatide, the prescription drug sold under brand names such as Mounjaro and Zepbound
Consequently, diabetic subjects treated with GLP-1 receptor agonists often experience weight loss as opposed to the weight gain commonly induced with other treatment agents
During the adaptation phase, these systems are adjusting